Human Papilloma Virus (HPV) Self-collection and Women Adherence
Launched by INSTITUTO NACIONAL DE CANCEROLOGIA, COLUMBIA · Sep 23, 2021
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
The investigators will perform a randomized clinical trial with three arms including: regular HPV with cytology triage, colpo/biopsy, and treatment if indicated; HPV self-collection without cytology triage but with colpo/biopsy and treatment if indicated, HPV self-collection with immediate treatment for women with positive test results. This study will be carried out in two different settings with differential access to diagnosis and treatment. Two methods will be used for inviting women and collecting samples: mail and door-to-door. Participation (screening uptake) and adherence to the cli...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women 30-65 years old
- • No history of cytology or any other screening test for cancer of the cervix in the past 5 years
- • Be linked to one of the health providing entities participating in the study
- • Women who sign the informed consent.
- Exclusion Criteria:
- • Women 30-65 years old
- • No history of cytology or any other screening test for cancer of the cervix in the past 5 years
- • Be linked to one of the health providing entities participating in the study
- • Women who sign the informed consent.
About Instituto Nacional De Cancerologia, Columbia
The Instituto Nacional de Cancerología (INC) in Colombia is a leading clinical trial sponsor dedicated to advancing cancer research and improving patient outcomes through innovative therapeutic interventions. As a premier institution in oncology, INC conducts rigorous clinical trials that adhere to the highest standards of scientific integrity and ethical practice. With a multidisciplinary team of experts, the institute focuses on developing and evaluating novel treatment modalities, fostering collaboration with national and international research entities, and contributing to the global body of cancer knowledge. Its commitment to patient-centered care and groundbreaking research positions INC at the forefront of cancer treatment advancements in Colombia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bogotá, Cundinamarca, Colombia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials